Taysha Gene Therapies, Inc. revenue for the last year amounted to 8.33 M USD, the most of which — 8.33 M USD — came from its highest performing source at the moment, Gene Therapy, the year earlier bringing 15.45 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Taysha Gene Therapies, Inc. 8.33 M USD, and the year before that — 15.45 M USD.